中文版 | English
Title

CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin

Author
Corresponding AuthorLong, Ying; Wang, Jigang; Li, Zhijie
Publication Years
2022-11-26
DOI
Source Title
ISSN
1226-4601
EISSN
2055-7124
Volume26Issue:1
Abstract
["Background: It is highly desirable to develop new therapeutic strategies for gastric cancer given the low survival rate despite improvement in the past decades. Cadherin 17 (CDH17) is a membrane protein highly expressed in cancers of digestive system. Nanobody represents a novel antibody format for cancer targeted imaging and drug delivery. Nanobody targeting CHD17 as an imaging probe and a delivery vehicle of toxin remains to be explored for its theragnostic potential in gastric cancer.","Methods: Naive nanobody phage library was screened against CDH17 Domain 1-3 and identified nanobodies were extensively characterized with various assays. Nanobodies labeled with imaging probe were tested in vitro and in vivo for gastric cancer detection. A CDH17 Nanobody fused with toxin PE38 was evaluated for gastric cancer inhibition in vitro and in vivo.","Results: Two nanobodies (Al and E8) against human CDH17 with high affinity and high specificity were successfully obtained. These nanobodies could specifically bind to CDH17 protein and CDH17-positive gastric cancer cells. E8 nanobody as a lead was extensively determined for tumor imaging and drug delivery. It could efficiently co-localize with CDH17-positive gastric cancer cells in zebrafish embryos and rapidly visualize the tumor mass in mice within 3 h when conjugated with imaging dyes. E8 nanobody fused with toxin PE38 showed excellent anti-tumor effect and remarkably improved the mice survival in cell-derived (CDX) and patient-derived xenograft (PDX) models. The immunotoxin also enhanced the anti-tumor effect of clinical drug 5-Fluorouracil.","Conclusions: The study presents a novel imaging and drug delivery strategy by targeting CDH17. CDH17 nanobody-based immunotoxin is potentially a promising therapeutic modality for clinical translation against gastric cancer."]
Keywords
URL[Source Record]
Indexed By
Language
English
SUSTech Authorship
First ; Corresponding
Funding Project
Basic and Applied Basic Research Foundation of GuangDong Province["2021A1515012164","2021A1515111188"] ; International Science and Technology Cooperation for Shenzhen Technology Innovation Plan[GJHZ20200731095411034] ; National Key Research and Development Program of China["2020YFA0908000","2022YFC2303600"] ; Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine[ZYYCXTDC-202002] ; Shenzhen Science and Technology Innovation Commission["JCYJ20210324115800001","JCYJ20210324114014039"] ; National Natural Science Foundation of China["82074098","81841001","82274182"]
WOS Research Area
Engineering ; Materials Science
WOS Subject
Engineering, Biomedical ; Materials Science, Biomaterials
WOS Accession No
WOS:000888816400002
Publisher
Data Source
Web of Science
Citation statistics
Cited Times [WOS]:2
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/417072
DepartmentShenzhen People's Hospital
Affiliation
1.Jinan Univ, Southern Univ Sci & Technol, Affiliated Hosp 1, Dept Hyperbar Med,Shenzhen Peoples Hosp,Clin Med, Shenzhen 518020, Guangdong, Peoples R China
2.Tianjin Univ Tradit Chinese Med, Coll Tradit Chinese Med, Tianjin 300193, Peoples R China
3.Jinan Univ, Southern Univ Sci & Technol, Affiliated Hosp 1, Dept Geriatr,Shenzhen Peoples Hosp,Clin Med Coll, Shenzhen 518020, Guangdong, Peoples R China
4.Wuhan Univ, Dept Hepatobiliary & Pancreat Surg, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China
5.Southern Med Univ, Nanfang Hosp, Clin Pharm Ctr, Guangzhou 510515, Guangdong, Peoples R China
6.Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China
7.Shenzhen Technol Univ, Coll Pharm, Shenzhen 518118, Peoples R China
8.Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518055, Guangdong, Peoples R China
9.Karolinska Inst, Dept Biosci & Nutr, S-14157 Stockholm, Sweden
10.Univ Hong Kong, Dept Chem, Pok Fu Lam, Hong Kong, Peoples R China
11.Shanxi Datong Univ, Sch Chem & Chem Engn, Xing Yun St, Datong 037009, Shanxi, Peoples R China
12.China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing 100700, Peoples R China
13.China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China
First Author AffilicationShenzhen People's Hospital
Corresponding Author AffilicationShenzhen People's Hospital
First Author's First AffilicationShenzhen People's Hospital
Recommended Citation
GB/T 7714
Ma, Jingbo,Xu, Xiaolong,Fu, Chunjin,et al. CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin[J]. Biomaterials Research,2022,26(1).
APA
Ma, Jingbo.,Xu, Xiaolong.,Fu, Chunjin.,Xia, Peng.,Tian, Ming.,...&Li, Zhijie.(2022).CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin.Biomaterials Research,26(1).
MLA
Ma, Jingbo,et al."CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin".Biomaterials Research 26.1(2022).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Ma, Jingbo]'s Articles
[Xu, Xiaolong]'s Articles
[Fu, Chunjin]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[Ma, Jingbo]'s Articles
[Xu, Xiaolong]'s Articles
[Fu, Chunjin]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Ma, Jingbo]'s Articles
[Xu, Xiaolong]'s Articles
[Fu, Chunjin]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.